Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Get email alerts on the Healthcare Finance topic
No spam. Unsubscribe anytime.
Republicans urge caution on 340B changes and medical‑debt fixes, warn of hospital impacts
Summary
Leaders said changes to the 340B drug‑pricing program and proposals to eliminate interest on medical debt could have unintended fiscal consequences for hospitals and patients; they called for careful hearings and warned of overlapping federal limits.
Reporters asked about the 340B drug‑pricing program and a bill to eliminate interest on medical debt. Republican leadership said the topic is complex, blends state and federal rules, and requires careful legislative work to avoid harming hospitals or patients.
Stokesberry and Braun said some hospitals feel they have been severely affected by recent policy changes and cited a compilation of measures they said cost hospitals more than $300,000,000 a year (including caps on public‑sector reimbursements, surcharges and Medicaid reductions). They said changes to 340B could impose costs on hospitals or reduce benefits to patients, and that federal law constrains state action.
On the medical‑debt question, representatives said they had not yet reviewed the bill eliminating interest in detail. One speaker (whose district includes small hospitals) said high charity‑care and unpaid bills already threaten small hospitals’ finances and that removing interest entirely could increase unpaid debt and pressure hospitals.
Why it matters: Changes to 340B or medical‑debt rules can shift costs among hospitals, insurers, pharmaceutical companies, and patients. Republican leaders said the legislature must balance protecting patients from burdensome debt and maintaining the financial viability of local hospitals.
Next steps: Leaders said they would review bill language and allow hearings so advocates and detractors can present evidence; no votes or formal endorsements were announced at the availability.
